n-3 fatty acids and serum lipoproteins: human studies
Open Access
- 1 May 1997
- journal article
- review article
- Published by Elsevier in The American Journal of Clinical Nutrition
- Vol. 65 (5) , 1645S-1654S
- https://doi.org/10.1093/ajcn/65.5.1645s
Abstract
The effects of n-3 fatty acids from fish oils (eicosapentaenoic acid and docosahexaenoic acid) and plant oils (alpha-linolenic acid) on human serum lipids and lipoproteins are reviewed. Studies were included in this review if they were placebo-controlled, crossover, or parallel design studies providing < 7 g n-3 fatty acids/d and with treatment periods of > or = 2 wk duration. Only three studies were available for evaluation of the effects of alpha-linolenic acid on serum lipid concentrations. From these studies it appeared that alpha-linolenic acid (18:3n-3) was equivalent to n-6-rich oils vis-vis lipid and lipoprotein effects. Only when very large amounts of flaxseed oil were fed did the hallmark effect of marine n-3 fatty acids-reduced triacylglycerol concentrations-appear. Thus, in terms of effects on lipoprotein metabolism, the plant-derived n-3 fatty acid is not equivalent to the marine-based acids. More studies using the marine-based acids were examined and summarized. Both crossover (n = 36) and parallel (n = 29) design studies reached the same conclusions: total cholesterol is not materially affected by n-3 fatty acid consumption, low-density-lipoprotein cholesterol concentrations tend to rise by 5-10% and high-density-lipoprotein cholesterol by 1-3%, and serum triacylglycerol concentrations decrease by 25-30%. These effects of marine n-3 fatty acids are now well-established; what remains is to determine the mechanisms behind these effects and, more importantly, their health consequences.Keywords
This publication has 72 references indexed in Scilit:
- Fish oil in lupus nephritis: Clinical findings and methodological implicationsKidney International, 1993
- Supplementation with n‐3 fatty acids reduces triglycerides but increases PAI‐1 in non‐insulin‐dependent diabetes mellitusEuropean Journal of Clinical Investigation, 1992
- Eicosapentaenoic acid ethyl ester as an antithrombotic agent: comparison to an extract of fish oilBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1991
- Effects of two types of fish oil supplements on serum lipids and plasma phospholipid fatty acids in coronary artery diseaseThe American Journal of Cardiology, 1990
- Effect of eicosapentaenoic acid on restenosis rate, clinical course and blood lipids in patients after percutaneous transluminal coronary angioplastyAustralian and New Zealand Journal of Medicine, 1990
- Partial Normalization by Dietary Cod-Liver Oil of Increased Microvascular Albumin Leakage in Patients with Insulin-Dependent Diabetes and AlbuminuriaNew England Journal of Medicine, 1989
- The Effect of Dietary Supplementation with n—3 Polyunsaturated Fatty Acids on the Synthesis of Interleukin-1 and Tumor Necrosis Factor by Mononuclear CellsNew England Journal of Medicine, 1989
- Cardiovascular Effects of n-3 Fatty AcidsNew England Journal of Medicine, 1988
- Fish Consumption and Mortality from Coronary Heart DiseaseNew England Journal of Medicine, 1985
- A double-blind, placebo-controlled trial of fish oil concentrate (MaxEpa) in stroke patients.Stroke, 1985